sequencing-based diagnostics
Inocras, IMBdx Partner on Cancer Diagnostics in US
The partnership between the two firms with South Korean roots will bring IMBdx's sequencing-based liquid biopsy tests to the US market.
Adaptive Biotechnologies Inks Partnership to Integrate MRD Assay With Epic's EMR System
After the expected integration in 2023, providers can order Adaptive’s ClonoSeq assay and review the results using the Epic electronic medical record system.
Although it has seemingly tried to do everything, everywhere, all at once with its immune sequencing technology, Adaptive has sharpened its focus.
Clarified Precision Medicine Acquires Molecular Diagnostics Firm Interpares Biomedicine
The acquisition brings Interpares' genetic sequencing test, OncoGuardian, into Clarified's portfolio of precision medicine products.
Congenica, Gabriel Precision Oncology Partner on Clinical Interpretation for Somatic Cancer Testing
University of Glasgow spinout Gabriel Precision Oncology will contribute a bioinformatics pipeline derived from cancer tissue samples to accelerate MDx adoption.